A Study of AT2101 (Afegostat Tartrate) in Adult Patients With Type 1 Gaucher Disease Currently Receiving Enzyme Replacement Therapy

NCT00433147 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Gaucher Disease, Type 1
Type 1 Gaucher Disease
Gaucher Disease

Interventions

DRUG: Afegostat tartrate

Sponsor

Amicus Therapeutics